Vedolizumab for the Treatment of Refractory Severe Rejection in Intestinal Transplantation
Sign Up to like & getrecommendations! Published in 2017 at "Transplantation"
DOI: 10.1097/01.tp.0000521364.18534.8f
Abstract: Introduction: Acute cellular rejection (ACR) is a continuous challenge in intestinal transplantation despite the advent of potent immunosuppressive drugs. Most of the traditional drugs used to treat ACR destroy specific cell lines with important systemic… read more here.
Keywords: intestinal transplantation; severe rejection; transplantation; vedolizumab treatment ... See more keywords